CTE's Principal Activity is the provision of supply chain logistics, management of pharmaceutical products used in clinical trials, management of biological materials and long-term storage of cord blood and tissue samples.
Last (Price) | |
Change | 0.00 (0.00) |
Bid / Ask | - |
Volume | |
Volume (4w avg) | |
Turnover | |
Open | |
Day Range | - |
VWAP | |
Prev Close | |
Last Trade |
1 Week | |
1 Month | |
2021 YTD | |
1 Year | |
vs Sector (1yr) | +325.90% |
vs ASX 200 (1yr) | +288.51% |
Market Capitalisation | |
ASX Rank | 1932 of 2,564 |
Sector Rank | 158 of 177 |
Date | Heading | Pages | File Size | Time |
---|---|---|---|---|
Cryosite Limited (CTE) is into provision of supply chain logistics, management of pharmaceutical products used in clinical trials, management of biological materials and long-term storage of cord blood and tissue samples. Cryosite operates through Clinical Trials & Biological Storage and Logistics and Cord Blood and Tissues Storage.
Incorporated in NSW in December 1999.
Head Office | South Granville NSW 2142 |
Website | www.cryosite.com |
Registry | Link Market Services |
Auditor | Mazars Risk & Assurance Pty Limited |
Date Listed | 9 May 2002 |
Date | Event |
---|---|
27/08/2021 | Report (Prelim) |
27/08/2021 | Report (Annual) |
24/02/2022 | Report (Interim) |
See Upcoming Dividends for all ASX companies.
Key Data | |
---|---|
DPS(TTM) | $0.00 |
Gross DPS(TTM) | $0.00 |
Dividend yield |
|
Gross yield |
|
Payout Ratio | 0% |
DRP | No |
DRP Features | -- |
CTE directors must report any change in shareholding to the ASX within 5 business days.
See Director Transactions for all ASX companies.
The current holdings of CTE directors.
A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.
Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.
Name | Last Notice | Total Shares | Shares Held (%) |
---|---|---|---|
Andrew John Kroger | 17/07/2020 | 18,889,612 | 40.31 |
DMX Asset Management Limited | 11/03/2021 | 2,770,973 | 5.91 |
Cell Care Australia Pty Ltd | 09/03/2021 | 6,913,807 | 14.75 |
12 month transaction history compiled from ASX announcements.
Date | Name | Bought | Previous % | New % |
---|---|---|---|---|
11-03-21 | DMX Asset Management Limited | 2,770,973 | -- | 5.91 |
17-04-20 | Andrew John Kroger | 49,422 | 40.21 | 40.31 |
12 month transaction history compiled from ASX announcements.
Date | Name | Sold | Previous % | New % |
---|---|---|---|---|
09-03-21 | Cell Care Australia Pty Ltd | 546,193 | 15.9 | 14.8 |
05-03-21 | Cell Care Australia Pty Ltd | 712,607 | 17.4 | 15.9 |
23-02-21 | Cell Care Australia Pty Ltd | 522,393 | 18.6 | 17.4 |
16-02-21 | Cell Care Australia Pty Ltd | 534,995 | 19.7 | 18.6 |
Date | Close | Change | %Chg | Open | High | Low | Volume | Turnover |
---|---|---|---|---|---|---|---|---|
Year | Closing Price | Last Trade |
---|---|---|
2020 | $0.13 | 30 June |
2019 | $0.05 | 28 June |
2018 | $0.09 | 29 June |
2017 | $0.16 | 28 June |
2016 | $0.21 | 28 June |
2015 | $0.35 | 30 June |
2014 | $0.36 | 30 June |
All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.